OLN324 Clinical-stage VEGF and Ang2 bispecific antibody entering Phase 3 development for diabetic macular edema and wet age-related macular degeneration.
Visit productCosigns Received
Be the first Cosign
Put your name behind OLN324.
Add it to your Products I use list and share why you use it.